Cytotoxicity evaluation of nanoclays in human epithelial cell line A549 using high content screening and real-time impedance analysis

Journal of Nanoparticle Research

Volumn 14, Issue 9, 2012, Pages

  Verma, Navin K ^a   Moore, Edward ^a   Blau, Werner ^a   Volkov, Yuri ^a   Babu, P Ramesh ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytotoxicity; High content screening; Impedance sensing; Nanoclay

Indexed keywords

BIOCOMPATIBILITY; BIOHAZARDS; CELL CULTURE; CELL PROLIFERATION; CELLS; CYTOTOXICITY; KAOLINITE; PLATELETS;

HEALTH AND SAFETY; HIGH-CONTENT SCREENING; HUMAN EPITHELIAL CELLS; IMPEDANCE ANALYSIS; IMPEDANCE SENSING; INTRACELLULAR ACCUMULATION; NANO CLAYS; PERINUCLEAR LOCALIZATION;

NANOCOMPOSITES;

NANOCLAY; NANOMATERIAL; UNCLASSIFIED DRUG;

A549 CELL; ARTICLE; BIOSAFETY; CELL GROWTH; CELL LINE; CONFOCAL MICROSCOPY; CYTOTOXICITY; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMPEDANCE; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84865294977     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-1137-5     Document Type: Article

References (21)

1. Ahamed M (2011) Toxic response of nickel nanoparticles in human lung epithelial A549 cells. Toxicol In Vitro 25:930-936
2. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K (2001) Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191-199 (Pubitemid 32917742)
3. Dong Y, Feng SS (2005) Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:6068-6076 (Pubitemid 40805612)
4. Floody MC, Theng BKG, Reyes P, Mora ML (2009) Natural nanoclays: Applications and future trends: A Chilean perspective. Clay Min 44:161-176
5. Kagan VE, Konduru NV, Feng W, Allen BL, Conroy J, Volkov Y, Vlasova II, Belikova NA, Yanamala N, Kapralov A, Tyurina YY, Shi J, Kisin ER, Murray AR, Franks J, Stolz D, Gou P, Seetharaman JK, Fadeel B, Star A, Shvedova AA (2010) Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nature Nanotechnol 5:354-359
6. Lin FH, Lee YH, Jian CH, Wong JM, Shieh MJ, Wang CY (2002) A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23:1981-1987 (Pubitemid 34251072)
7. Lordan S, Kennedy JE, Higginbotham CL (2011) Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line. J Appl Toxicol 31:27-35
8. Mohamed BM, Verma NK, Prina-Mello A, Williams Y, Davies AM, Bakos G, Tormey L, Edwards C, Hanrahan J, Salvati A, Lynch I, Dawson K, Kelleher D, Volkov Y (2011) Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnol 9:29
9. Napierska D, Thomassen LCJ, Lison D, Martens JA, Hoet PH (2010) The nanosilica hazard: Another variable entity. Part Fibre Toxicol 7:39
10. Nayak PL, Sahoo D (2011) Chitosan-alginate composites blended with cloisite 30B as a novel drug delivery system for anticancer drug paclitaxel. Int J Plast Technol 15:68-81
11. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622-627 (Pubitemid 43191298)
12. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005a) Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2:8
13. Oberdorster G, Oberdorster E, Oberdorster J (2005b) Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839 (Pubitemid 40984181)
14. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM (2006) Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296-303
15. Sharma AK, Schmidt B, Frandsen H, Jacobsen NR, Larsen EH, Binderup ML (2010) Genotoxicity of unmodified and organo-modified montmorillonite. Mutat Res 700:18-25
16. Soto K, Garza KM, Murr LE (2007) Cytotoxic effects of aggregated nanomaterials. Acta Biomater 3:351-358 (Pubitemid 46555129)
17. Stearns RC, Paulauskis JD, Godleski JJ (2001) Endocytosis of ultrafine particles by A549 cells. Am J Respir Cell Mol Biol 24:108-115 (Pubitemid 32152071)
18. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H (2006) Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect 114:328-333 (Pubitemid 43338255)
19. Suresh R, Borkar SN, Sawant VA, Shende VS, Dimble SK (2010) Nanoclay drug delivery system. Int J Pharm Sci Nanotechnol 3:901-905
20. Warheit DB (2008) How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183-185
21. Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL (2006) Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol Sci 91:227-236